Becton Dickinson (BDX) Reports FDA 510(k) Clearance for New Blood Collection Device
Tweet Send to a Friend
BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and European ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
